Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer
Disease Models & Mechanisms · 16.11.2026
DOI: 10.1242/dmm.052863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 16.11.2026. Verfasst von David J Klinke und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, U.S. National Science Foundation, National Cancer Institute.
Abstract (Originalsprache)
Cell Communication Network factor 4 (CCN4/WISP1) is a matricellular protein secreted by cancer cells that is upregulated in essentially all invasive breast cancers and promotes immunosuppression in melanoma. Limited anti-tumor immunity associates with poor patient outcomes in breast cancer, and elevated CCN4 correlates with dampened anti-tumor immunity in primary breast cancer tumors. To test for a direct causal link, we knocked out CCN4 in the Py230 and Py8119 syngeneic mouse breast cancer models. CCN4 knockout dramatically prolonged tumor-free survival in immunocompetent but not immunodeficient mice, establishing that CCN4's tumor-promoting effects are immune-dependent. In size-matched tumors, CCN4 knockout increases CD45+ infiltration and shifts the myeloid compartment from polymorphonuclear- to monocytic-myeloid-derived suppressor cells (MDSCs), changes accompanied by a significant reduction in splenomegaly consistent with a systemic as well as local effect. CCN4 knockout produces convergent secretome changes across both breast cancer and melanoma cell lines, pointing to a conserved immunosuppressive program. Analysis of TCGA breast cancer data further reveals that genetic alterations converging on beta-catenin pathway activation, including CCN4 copy number amplification at a frequency comparable to ERBB2, are present in a substantial fraction of invasive breast cancers. Together, these findings establish CCN4 as a driver of tumor-induced immunosuppression in breast cancer and a promising target for combination with existing immunotherapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, USA.
- Department of Physiology, Pharmacology and Toxicology, West Virginia University, Morgantown, WV, USA.
ORCID-Profile: David J Klinke
Förderung
- NCI NIH HHS
- U.S. National Science Foundation
- National Cancer Institute
Zitieren
APA
Klinke, D. J., Razazan, A., Pirkey, A. C., & Deng, W. (2026). Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052863
Vancouver
Klinke DJ, Razazan A, Pirkey AC, Deng W. Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052863
BibTeX
@article{Klinke2026,
author = {Klinke, David J and Razazan, Atefeh and Pirkey, Anika C and Deng, Wentao},
title = {Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer},
journal = {Disease Models & Mechanisms},
year = {2026},
doi = {10.1242/dmm.052863}
}
EUVIMED